Published • loading... • Updated
Elanco Animal Health Moves Higher On Earnings Strength And Product Momentum - Elanco Animal Health (NYSE:
Summary by Benzinga
2 Articles
2 Articles
Revenue increased by 15%, reaching $1.37 billion.
·Brazil
Read Full Article
Elanco Animal Health Moves Higher On Earnings Strength And Product Momentum - Elanco Animal Health (NYSE:
Shares of Elanco Animal Health Incorporated (NYSE:ELAN) are trading higher on Wednesday, following a recent announcement regarding the approval of its products, Negasunt Powder and Tanidil, which received emergency use authorization. The animal health company also released better-than-expected first-quarter earnings. Elanco Stock Rises On Emergency Use Authorization Approvals The recent approval of Elanco’s Negasunt Powder (Coumaphos, Propoxur, …
·New York, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
